Advertisement
COLL vs FIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a StrongBuy and FIX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COLL’s FA Score shows that 1 FA rating(s) are green whileFIX’s FA Score has 2 green FA rating(s).
- COLL’s FA Score: 1 green, 4 red.
- FIX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COLL’s TA Score shows that 5 TA indicator(s) are bullish while FIX’s TA Score has 3 bullish TA indicator(s).
- COLL’s TA Score: 5 bullish, 5 bearish.
- FIX’s TA Score: 3 bullish, 5 bearish.
Price Growth
COLL (@Pharmaceuticals: Other) experienced а +1.25% price change this week, while FIX (@Engineering & Construction) price change was +2.92% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +14.84%. For the same industry, the average monthly price growth was +19.69%, and the average quarterly price growth was +76.99%.
The average weekly price growth across all stocks in the @Engineering & Construction industry was +0.56%. For the same industry, the average monthly price growth was +12.15%, and the average quarterly price growth was +7.50%.
Reported Earning Dates
COLL is expected to report earnings on Jul 31, 2025.
FIX is expected to report earnings on Jul 23, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+14.84% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Engineering & Construction (+0.56% weekly)Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
| COLL | FIX | COLL / FIX | |
| Capitalization | 1.24B | 16.9B | 7% |
| EBITDA | 308M | 901M | 34% |
| Gain YTD | 1.850 | 13.165 | 14% |
| P/E Ratio | 30.17 | 28.74 | 105% |
| Revenue | 567M | 7.32B | 8% |
| Total Cash | 311M | N/A | - |
| Total Debt | 674M | 278M | 242% |
COLL | FIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 55 | 22 | |
SMR RATING 1..100 | 46 | 26 | |
PRICE GROWTH RATING 1..100 | 55 | 39 | |
P/E GROWTH RATING 1..100 | 11 | 69 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
COLL's Valuation (60) in the Pharmaceuticals Other industry is in the same range as FIX (77) in the Engineering And Construction industry. This means that COLL’s stock grew similarly to FIX’s over the last 12 months.
FIX's Profit vs Risk Rating (22) in the Engineering And Construction industry is somewhat better than the same rating for COLL (55) in the Pharmaceuticals Other industry. This means that FIX’s stock grew somewhat faster than COLL’s over the last 12 months.
FIX's SMR Rating (26) in the Engineering And Construction industry is in the same range as COLL (46) in the Pharmaceuticals Other industry. This means that FIX’s stock grew similarly to COLL’s over the last 12 months.
FIX's Price Growth Rating (39) in the Engineering And Construction industry is in the same range as COLL (55) in the Pharmaceuticals Other industry. This means that FIX’s stock grew similarly to COLL’s over the last 12 months.
COLL's P/E Growth Rating (11) in the Pharmaceuticals Other industry is somewhat better than the same rating for FIX (69) in the Engineering And Construction industry. This means that COLL’s stock grew somewhat faster than FIX’s over the last 12 months.
| COLL | FIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 43% |
| Stochastic ODDS (%) | 2 days ago 68% | 4 days ago 60% |
| Momentum ODDS (%) | 2 days ago 68% | N/A |
| MACD ODDS (%) | 2 days ago 61% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 67% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 76% |
| Advances ODDS (%) | 4 days ago 71% | 4 days ago 76% |
| Declines ODDS (%) | 9 days ago 66% | 9 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 77% | 3 days ago 67% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 75% |
Advertisement